The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2008A Randomized, Double-Blind, Trial of Nexalin® vs. Placebo in Subjects with Early Parkinson's Disease
Objective/Rationale:
While the oral medications to treat PD are often quite effective in treating the physical symptoms (motor symptoms) such as tremor and stiffness, they may be associated with side... -
PD Subtypes, 2007Phenoprofiling PD
Parkinson's disease is generally characterized as a movement disorder. Over the last years, however, there has been an increasing awareness that many people with PD may also suffer so-called "non...
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006Treadmill Training and Gait-Related Disability in Parkinson’s Disease
Gait impairment resulting in loss of mobility is a major cause of disability in Parkinson's disease, and current therapy including levodopa, surgery and rehabilitation are inadequate to preserve...
-
Repositioning Drugs for PD, 2011Evaluation of a Specific DAT Inhibitor in Pre-clinical Models of Parkinson's Disease
Objective/Rationale:
MLR-1017 is a psychostimulant drug used clinically for a variety of neuropsychiatric and other applications, but has never been tested in Parkinson’s disease (PD). Levodopa is a... -
Research Grant, 2018The Effect of Psychological Stress on the Symptoms of Parkinson's Disease
Study Rationale:
Many people with Parkinson's disease (PD) experience chronic stress and associated disorders, such as depression, anxiety or both. Furthermore, many people with PD notice worsening of... -
LEAPS, 2011Supplement to 'Discovery of mGluR4 Potentiators for Symptoms & Side Effects and Disease-Modifying Treatment of PD'
Promising Outcomes of Original Grant:
Activation or potentiation of metabotropic glutamate receptor 4 (mGluR4) is a promising new strategy for both Symptoms & Side Effects and disease-modifying...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.